Clinical Trials Browser

OTHER × Has results × Non-Muscle Invasive Bladder Neoplasms × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04386746 2025-11-17

GEMDOCE

Phase 2 Active not recruiting

27 enrolled 9 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03933826 2025-11-04

CISTO

Active not recruiting

570 enrolled 27 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT02695771 2023-04-21

BIC

Phase 3 Completed

101 enrolled 11 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03498196 2020-08-24

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Phase 1/2 Terminated

1 enrolled 10 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT00734994 2015-06-29

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

Phase EARLY_PHASE1 Completed

15 enrolled 5 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02207608 2015-05-28

Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects

Phase 2 Completed

30 enrolled 6 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

PERTINENCE

GEMDOCE

CISTO

BIC

A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects